Exercise Training and Respiratory Muscle Training in Individuals With Metabolic Syndrome(METS)
METS
The Effects of Exercise Training and Respiratory Muscle Training on Physical Fitness, Pulmonary Functions and METS Parameters in Individuals With METS
1 other identifier
interventional
38
1 country
1
Brief Summary
The study will be conducted on individuals with Metabolic Syndrome. There are many studies showing that aerobic exercise provides significant improvements in waist circumference, fasting glucose, high-density lipoprotein cholesterol (HDL-C), Triglyceride (TG), systolic and diastolic blood pressure (SBP-DBP), and cardiorespiratory fitness on METS parameters. However, although the beneficial effects of physical activity are known, only half of the population adheres to the 150 minutes of moderate-intensity physical activity per week recommendation. High-intensity interval training (HIIT) is a type of training that uses near-maximal intensities in short-term sessions. HIIT has been used to improve compliance because it requires less time to treat patients with cardiometabolic disease. Compared to continuous aerobic exercise, this type of training has been shown to be an effective alternative for improving maximum oxygen consumption (VO2 max), blood pressure, heart function, glucose and lipid metabolism, and markers of oxidative stress and inflammation. In the literature, HIIT has been studied in patients with METS and has been shown to be effective. In addition, a study showed that seven-day respiratory muscle training was also effective on METS parameters, but there is no study showing the long-term effects of respiratory muscle training in this patient group. Therefore, in our study, researchers aimed to show the effects of respiratory muscle training given with HIIT on METS parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedAugust 15, 2023
August 1, 2023
11 months
March 6, 2022
August 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2max
Cardiorespiratory fitness will be performed using a cardiopulmonary exercise test (CPET) with a treadmill, using the measurement method (breath by breath) with each breath. The modified Bruce protocol will be applied.VO2max will be recorded in ml/kg/min.
8 weeks
Secondary Outcomes (17)
functional capacity
8 weeks
flexibility
8 weeks
systolic and diastolic blood pressure
8 weeks
C-Reactive Protein (CRP)
8 weeks
Low Density Lipoprotein Cholesterol (LDL-C)
8 weeks
- +12 more secondary outcomes
Study Arms (3)
HIIT with a supervisor
EXPERIMENTALThese individuals will be given HIIT training on the treadmill, accompanied by a physiotherapist, 3 days a week for 8 weeks.
Hiit and respiratory muscle training with a supervisor
EXPERIMENTALHIIT program and respiratory muscle training will be applied to these individuals 3 days a week for 8 weeks.
control group
NO INTERVENTIONThe importance of physical activity will be explained and appropriate physical activity recommendations will be made.
Interventions
high-intensity interval training will be performed on the treadmill.
Respiratory muscle strength exercise will be performed with the respiratory muscle strengthening device 'POWERbreathe Classic Light Resistance'.
Eligibility Criteria
You may qualify if:
- METS will be defined according to the National Adult Cholesterol Education Program Adult Treatment Panel III. Patients with at least three or more of the following five characteristics will be included in the study:
- Waist circumference ≥102 cm for men or ≥88 cm for women;
- blood pressure above 130/85 mmHg;
- Fasting blood glucose (FG) ≥100 mg/dL;
- Blood TG ≥150 mg/dL; and
- HDL-C \< 40 mg/dL for men and \< 50 mg/dL for women.
- Not participating in any physical activity program (≤2 physical activity days per week ≤ 30 minutes per session).
- years
- to walk and cooperate
- to participate in the research
You may not qualify if:
- heart failure,
- pectoris,
- of myocardial infarction or stroke in less than one year,
- hypertension,
- cardiovascular or kidney disease,
- with peripheral vascular disease and any disease associated with exercise intolerance will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
oğuz uyaroglu, PHD
Hacettepe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The physician who referred patients to the study and the participants were blind to the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master off degree
Study Record Dates
First Submitted
March 6, 2022
First Posted
June 10, 2022
Study Start
April 1, 2022
Primary Completion
March 1, 2023
Study Completion
April 1, 2023
Last Updated
August 15, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
Study protocol and data analysis will be shared with other researchers.